MATES SHARON,LI PENG,WENNOGLE LAWRENCE P,DAVIS ROBERT
申请号：
IN201617036325
公开号：
IN201617036325A
申请日:
2016.10.24
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The invention relates to particular substituted heterocycle fused gamma carbolines their prodrugs in free solid pharmaceutically acceptable salt and/or substantially pure form as described herein pharmaceutical compositions thereof and methods of use in the treatment of diseases involving 5 HT receptor serotonin transporter (SERT) and/or pathways involving dopamine D/D receptor signaling systems and/or the treatment of residual symptoms.
